TeamDrive
RUS

Media Center

Media about us

  • 12 January 2018

    Corneal inlays need a boost from eye care providers

    Corneal inlays need a boost from eye care providers

    The Raindrop corneal inlay from ReVision Optics and the AcuFocus Kamra corneal inlay have been implanted in thousands of eyes. Ninety-five percent of patients with these devices report being quite satisfied, according to surveys, and virtually all implanting surgeons report they would recommend the procedures to their colleagues.

  • 28 December 2017

    NovaMedica Innotech R&D center meets Russian GMP standards

    NovaMedica Innotech R&D center meets Russian GMP standards

    NovaMedica, a Russian pharmaceutical company and investment project of RUSNANO, announced that it received the conclusion of the Russian Ministry of Industry and Trade on the compliance of the production site of NovaMedica Innotech R&D center, a subsidiary of NovaMedica, with the Russian Good Manufacturing Practice (GMP) standards.

All publications

Our news

  • 29 August 2017

    "Venture capital, is it obsolete today? I do not think so.." Author's column of Maxim Gorbachev

    "Venture capital, is it obsolete today? I do not think so.." Author's column of Maxim Gorbachev

    Maxim Gorbachev, Managing Partner of RMI Partners: "New technologies make dramatic changes to business. They even reached financing of venture capital companies. Use of crypto-currency has resulted into development of the new mechanism of crowdfunding – Initial Coin Offering (ICO) which is in a way similar to public share placement (IPO). Venture projects utilize blockchain technologies to create and sell digital tokens, thus raising funds from investors. When initially ICO was used as mechanism to develop new crypto-currency instruments such as Ethereum, nowadays ICO serve as a democratic mechanism of fund raising for any project. And this instrument cannot be ignored due to amounts of funds raised this way."   

  • 11 August 2017

    NovaMedica appoints Rustam Iksanov as R&D Vice President

    NovaMedica appoints Rustam Iksanov as R&D Vice President

    Rustam Iksanov, who used to hold one of the managerial positions in Valenta Pharma, has been appointed as R&D Vice President of pharmaceutical company NovaMedica.

  • 29 May 2017

    NovaMedica appoints Alexander Kuzin as General Director (CEO)

    NovaMedica appoints Alexander Kuzin as General Director (CEO)

    Russian pharmaceutical company NovaMedica, a portfolio company of RUSNANO, announces the appointment of Alexander Kuzin to the post of General Director (CEO). This decision has taken unanimously by the Board of Directors of NovaMedica on May 26, 2017.

All publications

In the spotlight

  • 30 May 2017

    NovaMedica began construction of a pharmaceutical plant in the Kaluga region

    NovaMedica began construction of a pharmaceutical plant in the Kaluga region

    Russian pharmaceutical company NovaMedica, a portfolio company of RUSNANO, announces the start of construction of a plant for the production of sterile injectable drugs as part of its long-term strategy to localize innovative medicines and technologies of their development and production in Russia. The plant will be built in the industrial park “Vorsino” in the Kaluga region.

Read more

Industry news

  • 16 January 2018

    The coming of age of gene therapy: A review of the past and path forward

    After three decades of hopes tempered by setbacks, gene therapy—the process of treating a disease by modifying a person’s DNA—is no longer the future of medicine, but is part of the present-day clinical treatment toolkit. The Jan. 12 issue of the journal Science provides an in-depth and timely review of the key developments that have led to several successful gene therapy treatments for patients with serious medical conditions.

  • 16 January 2018

    Russia approves the mechanism for introducing the medicines into circulation

    A draft federal law on the introduction of medicinal products for human use into civil circulation was prepared by the Russian Ministry of Health. The bill proposes to establish a more effective legal regulation of relations associated with the elaboration, application and enforcement of requirements in the area of circulation of medicinal products for human use, namely, by establishing a mechanism for release control of medicines coming into the civil circulation in Russia.

  • 15 January 2018

    Drug discovery IT solutions will reach $5.3 billion globally by 2020

    The latest analysis, Growth Insights – Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020, by Frost & Sullivan highlights the growing interest in big data analytics and artificial intelligence (AI)-based solutions.

  • 15 January 2018

    Clinical trials of Russian polio vaccine will be completed by mid-2018

    Russian scientists plan to complete the clinical trials of domestically developed inactivated polio vaccine by mid-2018 and are preparing the documents required for the registration of this drug. This was announced by Aidar Ishmukhametov, the Director of M.P. Chumakov Federal Scientific Center for Research and Development of Immunobiological Products of Russian Academy of Sciences.

All industry news

Date search